🧪 We show this in our recently published ACS
@JCIM_JCTC paper, elucidating the mechanistic basis by which Siponimod, a drug for #multiplesclerosis (MS), avoids off-target activation.
pubs.acs.org/doi/10.1021/...
🧪 We show this in our recently published ACS
@JCIM_JCTC paper, elucidating the mechanistic basis by which Siponimod, a drug for #multiplesclerosis (MS), avoids off-target activation.
pubs.acs.org/doi/10.1021/...
Meet Chanukya Nanduru to see Aganitha Igniva™ Agentic AI workflows for R&D and TechOps -
🧬 (Bio)molecular discovery & development
🧪 Structural modeling
⚗️ Catalyst / enzyme selection & optimization
💊 Formulation
🏭 Unit ops digital twins
Meet Chanukya Nanduru to see Aganitha Igniva™ Agentic AI workflows for R&D and TechOps -
🧬 (Bio)molecular discovery & development
🧪 Structural modeling
⚗️ Catalyst / enzyme selection & optimization
💊 Formulation
🏭 Unit ops digital twins
👉 Join us at AIPM-India 2025 in IIT Madras to see in action, Igniva™ AI agents, built on 5+ years of global biopharma R&D collaborations by 100+ researchers at Aganitha.
👉 Join us at AIPM-India 2025 in IIT Madras to see in action, Igniva™ AI agents, built on 5+ years of global biopharma R&D collaborations by 100+ researchers at Aganitha.
www.aganitha.ai/solutions-fo...
www.aganitha.ai/solutions-fo...
Why should single cell #omics analysis still take months, even in 2025?
In this video, Ananya Jana explains the challenges single cell researchers face today and how DISTLL™ accelerates journey to insights.
youtu.be/dxszTx5YjKQ
Why should single cell #omics analysis still take months, even in 2025?
In this video, Ananya Jana explains the challenges single cell researchers face today and how DISTLL™ accelerates journey to insights.
youtu.be/dxszTx5YjKQ
Our immune system responds to context, not just content. #SingleCellOmics is helping us find the patterns and rules.
We’ll soon be unveiling DISTILL™ — our platform for single-cell studies, designed for the #AgenticAI era.
www.aganitha.ai/blogs/immuno...
Our immune system responds to context, not just content. #SingleCellOmics is helping us find the patterns and rules.
We’ll soon be unveiling DISTILL™ — our platform for single-cell studies, designed for the #AgenticAI era.
www.aganitha.ai/blogs/immuno...
A few days after KJ Muldoon was born, he was diagnosed with a rare genetic disorder. Doctors told his family:
“Your son is very sick. The best place in the world to be when your child is sick is next door.”
A few days after KJ Muldoon was born, he was diagnosed with a rare genetic disorder. Doctors told his family:
“Your son is very sick. The best place in the world to be when your child is sick is next door.”
Igniva is our suite of research agents that integrate #LLMs with scientific data, tools & workflows to tackle complex problems like variant effect analysis.
Igniva is our suite of research agents that integrate #LLMs with scientific data, tools & workflows to tackle complex problems like variant effect analysis.
www.aganitha.ai/science-focu...
www.aganitha.ai/science-focu...
🧬 Causal inference on biobank-scale genomics & plasma proteomics for Biomarker & Target identification
🧩 Deciphering role of non-coding variants in disease
🤖 AI-powered Variant Effect Prediction
🧬 Causal inference on biobank-scale genomics & plasma proteomics for Biomarker & Target identification
🧩 Deciphering role of non-coding variants in disease
🤖 AI-powered Variant Effect Prediction
Igniva™ #AgenticAI analyzes & reasons over biological, chemical & clinical datasets, knowledge bases, and computational & AI models, with human experts in the loop.
www.aganitha.ai/company/news...
Igniva™ #AgenticAI analyzes & reasons over biological, chemical & clinical datasets, knowledge bases, and computational & AI models, with human experts in the loop.
www.aganitha.ai/company/news...
Vikram Duvvoori, CEO of Aganitha.ai, will be presenting case studies showing how #GenerativeAl & in silico modeling are mining insights from deep science to accelerate #BioPharma R&D. Event details in the poster below. See you there.
Vikram Duvvoori, CEO of Aganitha.ai, will be presenting case studies showing how #GenerativeAl & in silico modeling are mining insights from deep science to accelerate #BioPharma R&D. Event details in the poster below. See you there.
Sharing our preprint describing how we used #GenAI to improve design of blood-brain-barrier (#BBB) penetrating #AAV viral vectors 🧶 for gene therapy in brain disorders
www.biorxiv.org/content/10.1...
Sharing our preprint describing how we used #GenAI to improve design of blood-brain-barrier (#BBB) penetrating #AAV viral vectors 🧶 for gene therapy in brain disorders
www.biorxiv.org/content/10.1...